Literature DB >> 18048712

Learning how to control biases in studies to identify adverse effects of drugs.

Martin Vessey1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18048712      PMCID： PMC2099407          DOI： 10.1177/014107680710001117

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  Investigation of relation between use of oral contraceptives and thromboembolic disease.

Authors:  M P Vessey; R Doll
Journal:  Br Med J       Date:  1968-04-27

2.  Case-control studies in the evaluation of drug-induced illness.

Authors:  H Jick; M P Vessey
Journal:  Am J Epidemiol       Date:  1978-01       Impact factor: 4.897

3.  Risk of venous thromboembolism in users of hormone replacement therapy.

Authors:  E Daly; M P Vessey; M M Hawkins; J L Carson; P Gough; S Marsh
Journal:  Lancet       Date:  1996-10-12       Impact factor: 79.321

4.  Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.

Authors:  H Jick; S S Jick; V Gurewich; M W Myers; C Vasilakis
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

5.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272
  5 in total
  2 in total

1.  Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey.

Authors:  Paul E Stang; Patrick B Ryan; J Marc Overhage; Martijn J Schuemie; Abraham G Hartzema; Emily Welebob
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

2.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.